10x Genomics (TXG) Total Liabilities (2018 - 2025)
Historic Total Liabilities for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $245.0 million.
- 10x Genomics' Total Liabilities rose 1752.36% to $245.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $245.0 million, marking a year-over-year increase of 1752.36%. This contributed to the annual value of $245.0 million for FY2025, which is 1752.36% up from last year.
- Latest data reveals that 10x Genomics reported Total Liabilities of $245.0 million as of Q4 2025, which was up 1752.36% from $242.2 million recorded in Q3 2025.
- In the past 5 years, 10x Genomics' Total Liabilities ranged from a high of $245.0 million in Q4 2025 and a low of $190.4 million during Q3 2021
- In the last 5 years, 10x Genomics' Total Liabilities had a median value of $206.2 million in 2024 and averaged $210.2 million.
- Per our database at Business Quant, 10x Genomics' Total Liabilities tumbled by 1246.78% in 2021 and then soared by 1752.36% in 2025.
- Over the past 5 years, 10x Genomics' Total Liabilities (Quarter) stood at $201.3 million in 2021, then grew by 10.92% to $223.2 million in 2022, then increased by 0.39% to $224.1 million in 2023, then decreased by 6.96% to $208.5 million in 2024, then increased by 17.52% to $245.0 million in 2025.
- Its Total Liabilities stands at $245.0 million for Q4 2025, versus $242.2 million for Q3 2025 and $206.7 million for Q2 2025.